Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...
Morningstar

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Valneva shares slump after the companies said the study's primary endpoint didn't meet statistical significance Pfizer and Valneva plan to seek regulatory approval for a Lyme disease vaccine.
Hosted on MSN

Pfizer to Sell Stake in Pandemic Vaccine Partner BioNTech

(Bloomberg) -- Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations. The US drugmaker is ...
journalgazette

Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China

HANGZHOU, China, Feb. 24, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization collaboration with Pfizer China for ...
BioSpace

Pfizer culls early PD-L1 asset after series of clinical wins, deals in cancer

Pfizer’s decision to cut its early-stage cancer asset was due to “strategic business reasons” and not driven by safety or ...

Why is Pfizer stock dropping Tuesday?

Pfizer Inc PFE shares are trading lower on Tuesday after the company and its COVID-19 vaccine partner paused an updated-shot trial, adding pressure as risk appetite stays soft with the S&P 500 trading ...